BloodPressureHeartMeds.Net

NDA submitted to the FDA for new osteoarthritis drug

August 07, 2017

"Caliper is committed to partnering with our customers to provide not only innovative technology, but also the technical expertise necessary to ensure the best quality data," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "The recent releases of IVIS Lumina XR and the XenoLight reagents show that we are responding to customer input in making optical imaging processes more convenient, multi-modal and integrated with the imaging techniques used in the clinic."

To make in vivo imaging routine and accessible for everyday research, Caliper distributes and supports a suite of aftermarket consumable products, including Bioware cell lines with both fluorescent and bioluminescent reporters, and XenoLight fluorescent labeling kits for proteins and antibodies. XenoLight DiR provides a fluorescent tracking dye to monitor stem cell migration, and the new family of Rediject substrates enable the detection of multiple luciferase reporters, including transgenic cell lines and BRET Q-Dots. XenoLight reagents exploit the unique combination of bioluminescent sensitivity and fluorescent spectral unmixing that characterizes the complete line of IVIS imaging systems.

Source: caliperls